ABT-869
Product Specifications
Background
ABT-869 (796967-16-3) ia a structurally novel, potent inhibitor of receptor tyrosine kinases inhibiting VEGFR and PDGFR and related kinases with IC50s= 3, 4, 4, 66, 3 and 14 nM for VEGFR1, VEGFR2, FLT3, PDGFRβ, CSF-1R and KIT respectively.1,2 Protects cells from necroptosis and rescues SIRS mice from TNF-α-induced shock and death.3 Exerts anti-obesity effects by promoting adipocyte browning.4 Inhibits angiogenesis.5
Conjugation
Unconjugated
Buffer
Off-white solid
Storage Conditions
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx309200-01 20 µg
HD Domain Containing Protein 3 (HDDC3) Antibody (HRP)
Sign In for Pricing
View Details abx309200-02 50 µg
HD Domain Containing Protein 3 (HDDC3) Antibody (HRP)
Sign In for Pricing
View Details abx309200-03 100 µg
HD Domain Containing Protein 3 (HDDC3) Antibody (HRP)
Sign In for Pricing
View Details abx309200-04 200 µg
HD Domain Containing Protein 3 (HDDC3) Antibody (HRP)
Sign In for Pricing
View Details abx309200-05 1 mg
HD Domain Containing Protein 3 (HDDC3) Antibody (HRP)
Sign In for Pricing
View Details 
TL302398 1 Kit
Probable hydrolase PNKD (PNKD) Human shRNA Plasmid Kit (Locus ID 25953)
Sign In for Pricing
View Details